BPC-157 Capsules
Oral Body Protection Compound
Oral capsule formulation of BPC-157, a 15-amino-acid partial sequence derived from human gastric juice protein BPC. Supplied as 60 capsules per bottle for enteral-route research. Subject of numerous rodent studies covering gastrointestinal mucosal integrity, tendon and ligament repair, and angiogenic endpoints. For laboratory research use only.
Modulates the nitric oxide system, upregulates growth-factor receptor expression (notably VEGFR2), and influences focal adhesion and fibroblast migration pathways in preclinical models.
For Research Use Only. Sold for in vitro laboratory research. Not for human or veterinary consumption. By purchasing, you confirm you are 21+ and a qualified research professional.
Same 15-residue sequence as injectable BPC-157, oral capsule form.
Every batch of BPC-157 Capsules ships with an independently conducted Certificate of Analysis by Janoshik Analytical or Bioviridian. The COA includes HPLC-MS chromatogram, mass spec confirmation, endotoxin levels, and heavy metals screening.
Batch number is printed on the vial label and included in your order confirmation email. Look it up at pepidyn.com/coa.
